These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

535 related items for PubMed ID: 17469026

  • 1. Renal cell carcinoma: a clinicopathological follow-up study after radical nephrectomy.
    Zubac DP, Bostad L, Gestblom C, Kihl B, Seidal T, Wentzel-Larsen T, Bakke AM.
    Scand J Urol Nephrol; 2007; 41(3):191-7. PubMed ID: 17469026
    [Abstract] [Full Text] [Related]

  • 2. Prognosticfactors in patients with renal cell carcinoma: is TNM (1997) staging relevant in Indian subpopulation?
    Srivastava A, Mandhani A, Kapoor R, Jain M, Dubey D, Srivastava A, Raghavendra M, Kumar A.
    Indian J Cancer; 2004; 41(3):99-103. PubMed ID: 15472406
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Prognostic value of renal vein and inferior vena cava involvement in renal cell carcinoma.
    Wagner B, Patard JJ, Méjean A, Bensalah K, Verhoest G, Zigeuner R, Ficarra V, Tostain J, Mulders P, Chautard D, Descotes JL, de la Taille A, Salomon L, Prayer-Galetti T, Cindolo L, Valéri A, Meyer N, Jacqmin D, Lang H.
    Eur Urol; 2009 Feb; 55(2):452-9. PubMed ID: 18692951
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. External validation of the Mayo Clinic stage, size, grade, and necrosis (SSIGN) score for clear-cell renal cell carcinoma in a single European centre applying routine pathology.
    Zigeuner R, Hutterer G, Chromecki T, Imamovic A, Kampel-Kettner K, Rehak P, Langner C, Pummer K.
    Eur Urol; 2010 Jan; 57(1):102-9. PubMed ID: 19062157
    [Abstract] [Full Text] [Related]

  • 7. Comparison of type I and II papillary renal cell carcinoma (RCC) and clear cell RCC.
    Waldert M, Haitel A, Marberger M, Katzenbeisser D, Ozsoy M, Stadler E, Remzi M.
    BJU Int; 2008 Nov; 102(10):1381-4. PubMed ID: 18782311
    [Abstract] [Full Text] [Related]

  • 8. Prognostic variables to predict cancer-related death in incidental renal tumours.
    Bensalah K, Pantuck AJ, Crepel M, Verhoest G, Méjean A, Valéri A, Ficarra V, Pfister C, Ferrière JM, Soulié M, Cindolo L, De La Taille A, Tostain J, Chautard D, Schips L, Zigeuner R, Abbou CC, Lobel B, Salomon L, Lechevallier E, Descotes JL, Guillé F, Colombel M, Belldegrun AS, Patard JJ.
    BJU Int; 2008 Nov; 102(10):1376-80. PubMed ID: 18727618
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Influence of tumour-associated symptoms on the prognosis of patients with renal cell carcinoma.
    Kawaciuk I, Hyrsl L, Dusek P, Jarolim L, Schmidt M, Kaliska V, Chocholaty M, Vesely S.
    Scand J Urol Nephrol; 2008 Nov; 42(5):406-11. PubMed ID: 18932106
    [Abstract] [Full Text] [Related]

  • 13. Impact of several histopathological prognosticators and local tumour extension on oncological outcome in pT3b/c N0M0 renal cell carcinoma.
    Roos FC, Weirich J, Victor A, Elsässer A, Brenner W, Biesterfeld S, Hampel C, Thüroff JW.
    BJU Int; 2009 Aug; 104(4):461-9. PubMed ID: 19338563
    [Abstract] [Full Text] [Related]

  • 14. Clinicopathologic and molecular correlations of necrosis in the primary tumor of patients with renal cell carcinoma.
    Lam JS, Shvarts O, Said JW, Pantuck AJ, Seligson DB, Aldridge ME, Bui MH, Liu X, Horvath S, Figlin RA, Belldegrun AS.
    Cancer; 2005 Jun 15; 103(12):2517-25. PubMed ID: 15880379
    [Abstract] [Full Text] [Related]

  • 15. Prognostic significance of the 1997 TNM classification of renal cell carcinoma.
    Javidan J, Stricker HJ, Tamboli P, Amin MB, Peabody JO, Deshpande A, Menon M, Amin MB.
    J Urol; 1999 Oct 15; 162(4):1277-81. PubMed ID: 10492179
    [Abstract] [Full Text] [Related]

  • 16. Survival analysis of 130 patients with papillary renal cell carcinoma: prognostic utility of type 1 and type 2 subclassification.
    Pignot G, Elie C, Conquy S, Vieillefond A, Flam T, Zerbib M, Debré B, Amsellem-Ouazana D.
    Urology; 2007 Feb 15; 69(2):230-5. PubMed ID: 17275070
    [Abstract] [Full Text] [Related]

  • 17. Prognostic impact of tumor size on pT2 renal cell carcinoma: an international multicenter experience.
    Klatte T, Patard JJ, Goel RH, Kleid MD, Guille F, Lobel B, Abbou CC, De La Taille A, Tostain J, Cindolo L, Altieri V, Ficarra V, Artibani W, Prayer-Galetti T, Allhoff EP, Schips L, Zigeuner R, Figlin RA, Kabbinavar FF, Pantuck AJ, Belldegrun AS, Lam JS.
    J Urol; 2007 Jul 15; 178(1):35-40; discussion 40. PubMed ID: 17521678
    [Abstract] [Full Text] [Related]

  • 18. Prognostic value of microscopic venous invasion in renal cell carcinoma: long-term follow-up.
    Lang H, Lindner V, Letourneux H, Martin M, Saussine C, Jacqmin D.
    Eur Urol; 2004 Sep 15; 46(3):331-5. PubMed ID: 15306103
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Unclassified renal cell carcinoma: a report of 56 cases.
    Lopez-Beltran A, Kirkali Z, Montironi R, Blanca A, Algaba F, Scarpelli M, Yorukoglu K, Hartmann A, Cheng L.
    BJU Int; 2012 Sep 15; 110(6):786-93. PubMed ID: 22404824
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 27.